PRKD1 and pancreatitis: To determine whether the two small molecule PKD inhibitors blocked NF-κB activation in the CCK analog cerulein-induced animal model of pancreatitis, we first tested their in vivo selectivity and specificity for PKD when the inhibitors were administered to animals.